海外の治験の状況「前立腺癌」での検索結果
167件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Not recruiting
- Sunitinib Plus Prednisone In Patients With Metastatic Castration-Resistant Prostate Cancer After Failure Of Docetaxel Chemotherapy
- Prostatic Neoplasms;Prostatic Neoplasms;Prostatic Neoplasms;Prostatic Neoplasms
- Australia, Belgium, Brazil, Canada, China, Czech Republic, Denmark, Finland, France, Germany, Israel, Italy, Korea, Republic of, Peru, Poland, Portugal, Slovakia, Spain, Sweden, Taiwan, United Kingdom, United States
- 2008-05-08
Recruiting
- Study of Abiraterone Acetate Plus ADT Versus APALUTAMIDE Versus Abiraterone and APALUTAMIDE in Patients With Advanced Prostate Cancer With Non-castrate Testosterone Levels
- Prostate Cancer;Prostate Cancer;Prostate Cancer;Prostate Cancer
- Brazil
- 2016-08-08
Not recruiting
- XRP6258 Plus Prednisone Compared to Mitoxantrone Plus Prednisone in Hormone Refractory Metastatic Prostate Cancer
- Neoplasms;Prostatic Neoplasms;Neoplasms;Prostatic Neoplasms;Neoplasms;Prostatic Neoplasms;Neoplasms;Prostatic Neoplasms
- Argentina, Belgium, Brazil, Canada, Chile, Czech Republic, Denmark, Finland, France, Germany, Hungary, India, Italy, Korea, Republic of, Mexico, Netherlands, Poland, Russian Federation, Singapore, Slovakia, South Africa, Spain, Sweden, Taiwan, Turkey, United Kingdom, United States, Uruguay
- 2006-12-28
Not recruiting
- "REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk
- Neoplasms, Prostate;Neoplasms, Prostate;Neoplasms, Prostate;Neoplasms, Prostate
- Argentina, Australia, Austria, Belarus, Belgium, Brazil, Bulgaria, Canada, Chile, Croatia, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Japan, Latvia, Lithuania, Mexico, Netherlands, New Zealand, Norway, Poland, Portugal, Puerto Rico, Romania, Russian Federation, Slovakia, Slovenia, South Africa, Spain, Sweden, Switzerland, Tunisia, Turkey, Ukraine, United Kingdom, United States
- 2003-03-11
Not recruiting
- Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-resistant Prostate Cancer
- Prostatic Neoplasms;Prostatic Neoplasms;Prostatic Neoplasms;Prostatic Neoplasms
- Argentina, Australia, Brazil, Canada, Czech Republic, Finland, France, Germany, Greece, Hungary, India, Ireland, Italy, Korea, Republic of, Mexico, Norway, Peru, Poland, Romania, Russian Federation, South Africa, Spain, Sweden, United Kingdom, United States
- 2008-08-29
Recruiting
- Evaluation of Post-operative Biochemical Recurrence in Patients Submitted to Radical Prostatectomy Under General Opioid-free Anesthesia Compared to Conventional General Anesthesia
- Prostate Cancer;Prostate Cancer;Prostate Cancer;Prostate Cancer
- Brazil
- 2017-04-10
Not recruiting
- Trial Comparing Intensity Modulated Radiotherapy Versus Conformal Radiotherapy to Treat Prostate Cancer With Hypofractionated Schedule
- Prostate Cancer
- Brazil
- 2014-09-29
Not Recruiting
- AFFIRM: A Multinational Phase 3, Randomized, Double-Blind, Placebo-COntrolled Efficacy and Safety Study of Oral MDV3100 in Patients With Progressive Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy
- Castration-Resistant Prostate Cancer;C61 - Malignant neoplasm of prostate
- Argentina, Australia, Austria, Belgium, Canada, Chile, France, Germany, Italy, Netherlands, Poland, South Africa, Spain, United Kingdom, United States
- 2014-04-14
Not Recruiting
- A Three Arm Randomized, Open-label Phase II Study of Radium-223 Dichloride 50 kBq/kg (55 kBq/kg After Implementation of NIST Update) Versus 80 kBq/kg (88 kBq/kg After Implementation of NIST Update), and Versus 50 kBq/kg (55 kBq/kg After Implementation of NIST Update) in an Extended Dosing Schedule in Subjects With Castration-resistant Prostate Cancer Metastatic to the Bone
- Prostatic Neoplasms;C61 - Malignant neoplasm of prostate
- Australia, Brazil, Canada, Chile, Czech Republic, Finland, France, Germany, Israel, Italy, Korea, Republic of, Poland, Spain, Sweden, Taiwan, Province of China, United Kingdom, United States
- 2015-06-25
Not Recruiting
- A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
- Prostate Cancer;C61 - Malignant neoplasm of prostate
- Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Czech Republic, Estonia, France, Germany, Greece, India, Israel, Italy, Korea, Republic of, Latvia, Lebanon, Lithuania, Mexico, Netherlands, New Zealand, Panama, Peru, Poland, Romania, Russian Federation, Slovakia, Spain, Sweden, Taiwan, Province of China, Turkey, Ukraine, United Kingdom, United States
- 2015-04-30